Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Acotec Scientific Holdings Limited ( (HK:6669) ) has provided an announcement.
Acotec Scientific Holdings Limited has scheduled a board meeting for March 26, 2026 to review and approve the audited annual results for the financial year ended December 31, 2025. At the same meeting, the board will also consider the publication of these results and the potential declaration of a final dividend, decisions that could affect shareholder returns and signal the company’s financial health and capital allocation priorities.
The most recent analyst rating on (HK:6669) stock is a Hold with a HK$15.00 price target. To see the full list of analyst forecasts on Acotec Scientific Holdings Limited stock, see the HK:6669 Stock Forecast page.
More about Acotec Scientific Holdings Limited
Acotec Scientific Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong under stock code 6669. It operates in the scientific and medical technology sector through a group structure that includes various subsidiaries, with an executive board led by Chairperson and CEO Jing Li and supported by non-executive and independent non-executive directors.
YTD Price Performance: -14.81%
Average Trading Volume: 317,762
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.6B
For a thorough assessment of 6669 stock, go to TipRanks’ Stock Analysis page.